Abraham Ceesay

Chief Executive Officer

Abraham Ceesay (Chief Executive Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $2.4M of RAPP (51,499 sh across 5 lots, as filed), executed Aug 10.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.9M

shares × price, as filed

Last traded

Sep 8

Filed Sep 9

Median ADV $17.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $6.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

RAPP

Rapport Therapeutics, Inc. RAPP · 0 buys · 9 sells 9 filings

Recent filings

RAPPSALE Rapport Therapeutics, Inc. View filing → $325K
7,141 sh × $45.55
Exec Sep 8
Filed Sep 9 · 4:05 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $938K
18,921 sh × $49.57
Exec Aug 25
Filed Aug 26 · 4:05 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $2.4M
51,499 sh across 5 lots
Exec Aug 10
Filed Aug 12 · 4:35 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $328K
8,210 sh across 2 lots
Exec Jul 14
Filed Jul 15 · 4:15 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $292K
7,344 sh × $39.77
Exec Jun 29
Filed Jul 1 · 4:05 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $103K
3,552 sh × $29.05
Exec Feb 18
Filed Feb 19 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $285K
10,916 sh across 2 lots
Exec Jan 20
Filed Jan 22 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $231K
8,975 sh across 2 lots
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET More filings →